
by Jared Kimble Now that we are entering into a new phase of discovery, the Identification of Medicinal Products (IDMP) has once again become a priority for the European Medicines Agency (EMA). After many delays and other scheduling problems, the industry must turn its attention to the standard but, rather than view it as just […]